I've seen down-rampers in this thread and they definitely do not give detailed information as I do. Shout out to that one guy that was down ramping prior to the release of Cohort 2 data at the SNO Conference in Nov 21.
I'm not down-ramping. I plan to buy in on this stock with more clarity whether that is lower or at 2x the price from here because CLTX CAR-T produced significant results. I don't care about the price. I care more about the clarity of where CLTX CAR-T is at.
If you think CLTX CAR-T is going to produce significant results at this point of this development stage that'll result in a 2x of its price at the release of their clinical trial results, please let me know why you think that'll be the case because I wouldn't mind 2x'ing my money from here. I'll be waiting...
Prices go down irrationally during bear markets (Amazon fell down 95% from ATH during the aftermath of the 2000 tech bubble burst, while being a profitable company). Is CHM undervalued, yes and it'll stay undervalued even at 4-5x the price from here. But can it still go down irrationally? yes definitely.
Also, it might be possible that the whole market including the XBI is currently experiencing a bear-market rally. I won't change my sentiment unless this breaks through and holds 96.85. For now, all I could say is that it was rejected a trend reversal hasn't occurred just yet.
(20min delay)